PDF herunterladen
Thromb Haemost 1994; 72(06): 869-873
DOI: 10.1055/s-0038-1648976
Original Article
Schattauer GmbH Stuttgart

Possible Structural Implications of 20 Mutations in the Protein C Protease Domain

Judith S Greengard
The Departments of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
,
John H Griffin
The Departments of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
,
Cindy L Fisher
The Departments of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 30. Mai 1994

Accepted after revision 08. August 1994

Publikationsdatum:
06. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary

Analysis of naturally occurring protein mutations yields valuable insights into functionally important sequences. Characterizing mutations responsible for protein C deficiency at the molecular level has been the subject of intensive investigation. In a previous study, a three-dimensional model of the serine protease domain of protein C was used to analyze the set of protease domain mutations previously available. The mutations were largely found to fall into a limited number of categories. A recently updated protein C mutation data base has provided a number of new mutations which have been analyzed for structural predictions.

 

  • References

  • 1 Rezaie AR, Esmon NL, Esmon CT. The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain. J Biol Chem 1992; 267: 11701-11704
    PubMedSuche in Google Scholar
  • 2 Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem 1992; 267: 26104-26109
    PubMedSuche in Google Scholar
  • 3 Rezaie AR, Mather R, Sussman F, Esmon CT. Mutation of Glu-80 → Lys results in a protein C mutant that no longer requires Ca2+ for rapid activation by the thrombin-thrombomodulin complex. J Biol Chem 1994; 269: 3151-3154
    PubMedSuche in Google Scholar
  • 4 Rezaie AR, Esmon CT. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors. J Biol Chem 1993; 268: 19943-19948
    PubMedSuche in Google Scholar
  • 5 Ehrlich HJ, Jaskunas R, Grinnell BW, Yan SB, Bang NU. Direct expression of recombinant activated human protein C, a serine protease. J Biol Chem 1989; 264: 14298-14304
    PubMedSuche in Google Scholar
  • 6 Yan SCB, Pazzano P, Chao YB, Walls JD, Berg DT, McClure DB, Grinnell BW. Characterization and novel purification of recombinant human protein C from three mammalian cell lines. Bio/Technology 1990; 8: 655-661
    CrossrefPubMedSuche in Google Scholar
  • 7 McClure DB, Walls JD, Grinnell BW. Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-depend-ent antithrombotic factor. J Biol Chem 1992; 267: 19710-19717
    PubMedSuche in Google Scholar
  • 8 Zhang L, Castellino FJ. Role of the hexapeptide disulfide loop present in the gamma-carboxyglutamic acid domain of human protein C in its activation properties and in the in vitro anticoagulant activity of activated protein C. Biochemistry 1991; 30: 6696-6704
    CrossrefPubMedSuche in Google Scholar
  • 9 Zhang L, Castellino FJ. A gamma-carboxyglutamic acid variant (gamma6D gamma7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 1990; 29: 10828-10834
    CrossrefPubMedSuche in Google Scholar
  • 10 Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood 1992; 80 (04) 942-952
    PubMedSuche in Google Scholar
  • 11 Fisher CL, Greengard JS, Griffin JH. Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen. Protein Science 1994; 3: 588-599
    PubMedSuche in Google Scholar
  • 12 Wacey AI, Pemberton S, Cooper DN, Kakkar VV, Tuddenham EGD. A molecular model of the serine protease domain of activated protein C: Application to the study of missense mutations causing protein C deficiency. Br J Haematol 1993; 84: 290-300
    CrossrefPubMedSuche in Google Scholar
  • 13 Greengard JS, Fisher CL, Villoutreix B, Griffin JH. Structural basis for Type I and Type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three-dimensional molecular modelling of mutations of the protease domain. Proteins 1994; 18: 367-380
    CrossrefPubMedSuche in Google Scholar
  • 14 Greer J. Comparative modeling methods: Application to the family of the mammalian serine proteases. Proteins 1990; 7: 317-334
    CrossrefPubMedSuche in Google Scholar
  • 15 Birktoft JJ, Blow DM. Structure of crystalline α-chymotrypsin (V). The atomic structure of tosyl-α-chymotrypsin at 2 Å resolution. J Mol Biol 1972; 68: 187-240
    CrossrefPubMedSuche in Google Scholar
  • 16 Witt I, Seydewitz HH, Asbeck D, Beck S, Nabel C. Protein C mutations in 10 unrelated families with symptomatic protein C deficiency. Ann Hematol 1994; 68 Suppl (Suppl. 02) A58
    PubMedSuche in Google Scholar
  • 17 Doig RG, Begley CG, McGrath KA. Three previously undescribed mutations of the protein C gene in families with hereditary protein C deficiency. Thromb Haemost 1993; 69: 644
    PubMedSuche in Google Scholar
  • 18 Miyata Z, Zheng Y-Z, Sakata T, Tsushima N, Kato H. Three missense mutations in the protein C heavy chain causing type I and type II protein C deficiency. Thromb Haemost 1994; 71 (01) 32-37
    Thieme ConnectPubMedSuche in Google Scholar
  • 19 Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 Å crystal structure of human alpha-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989; 8: 3467-3475
    PubMedSuche in Google Scholar
  • 20 Walter J, Steigemann W, Singh TP, Bartunik H, Bode W, Huber R. On the disordered activation domain in trypsinogen. Chemical labelling and low-temperature crystallography. Acta Crystallog, Sect B 1982; 38: 1462-1720
    PubMedSuche in Google Scholar
  • 21 Tsukada H, Blow DM. Structure of α-chymotrypsin refined at 1.68 Å resolution. J Mol Biol 1985; 184: 703-711
    CrossrefPubMedSuche in Google Scholar
  • 22 Wang D, Bode W, Huber R. Bovine chymotrypsinogen A. X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution J Mol Biol 1985; 185: 595-624
    CrossrefPubMedSuche in Google Scholar
  • 23 Collawn JF, Kuhn LA, Liu L-FS, Tainer JA, Trowbridge IS. Transplanted LDL and mannose-6-phosphate receptor internalization signals promote high-efficiency endocytosis of the transferrin receptor. EMBO J 1991; 10: 3247-3253
    PubMedSuche in Google Scholar
  • 24 Murakawa M, Okamura T, Kamura T, Kuroiwa M, Harada M, Niho Y. A comparative study of partial primary structures of the catalytic region of mammalian protein C. Br J Haematol 1994; 86: 590-600
    CrossrefPubMedSuche in Google Scholar
  • 25 Prevelige Jr P, Fasman GD. Chou-Fasman prediction of the secondary structure of proteins. The Chou-Fasman-Prevelige algorithm. In: Prediction of Protein Structure and the Principles of Protein Conformation Fasman GD. ed Plenum Press; 1989. pp 391-416
  • 26 Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W. Structure of human des(l–45) factor Xa at 2.2 Å resolution. J Mol Biol 1993; 232: 947-966
    CrossrefPubMedSuche in Google Scholar
  • 27 Mesters RM, Heeb MJ, Griffin JH. Interactions and inhibition of blood coagulation factor Va involving residues 311–325 of activated protein C. Protein Science 1993; 2: 1482-1489
    CrossrefPubMedSuche in Google Scholar
  • 28 Miyata T, Aruga R, Umeyama H, Bezeaud A, Guillin MC, Iwanaga S. Prothrombin Salakta: Substitution of glutamic acid-466 by alanine reduces fibrinogen clotting activity and the esterase activity. Biochemistry 1992; 31: 7457-7462
    CrossrefPubMedSuche in Google Scholar
  • 29 Braun PJ, Hofsteenge J, Chang JY, Stone SR. Preparation and characterization of proteolyzed forms of human α-thrombin. Thromb Res 1988; 50: 273-283
    CrossrefPubMedSuche in Google Scholar
  • 30 Hofsteenge J, Braun PJ, Stone SR. Enzymatic properties of proteolytic derivatives of human α-thrombin. Biochemistry 1988; 27: 2144-2151
    CrossrefPubMedSuche in Google Scholar
  • 31 Stubbs MT, Bode W. A player of many parts: The spotlight falls on thrombin’s structure. Thromb Res 1993; 69: 1-58
    CrossrefPubMedSuche in Google Scholar
  • 32 Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C deficiency: A database of mutations, 1995 Update. Thrombos Haemostas 1995 (in press)
    PubMedSuche in Google Scholar